238 related articles for article (PubMed ID: 31334382)
1. Reporting of master protocols towards a standardized approach: A systematic review.
Siden EG; Park JJ; Zoratti MJ; Dron L; Harari O; Thorlund K; Mills EJ
Contemp Clin Trials Commun; 2019 Sep; 15():100406. PubMed ID: 31334382
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols.
Park JJH; Siden E; Zoratti MJ; Dron L; Harari O; Singer J; Lester RT; Thorlund K; Mills EJ
Trials; 2019 Sep; 20(1):572. PubMed ID: 31533793
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials.
Lu CC; Li XN; Broglio K; Bycott P; Jiang Q; Li X; McGlothlin A; Tian H; Ye J
Ther Innov Regul Sci; 2021 Nov; 55(6):1145-1154. PubMed ID: 34160785
[TBL] [Abstract][Full Text] [Related]
5. The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review.
Meyer EL; Mesenbrink P; Dunger-Baldauf C; Fülle HJ; Glimm E; Li Y; Posch M; König F
Clin Ther; 2020 Jul; 42(7):1330-1360. PubMed ID: 32622783
[TBL] [Abstract][Full Text] [Related]
6. Master protocol trials in oncology: Review and new trial designs.
Hirakawa A; Asano J; Sato H; Teramukai S
Contemp Clin Trials Commun; 2018 Dec; 12():1-8. PubMed ID: 30182068
[TBL] [Abstract][Full Text] [Related]
7. An overview of precision oncology basket and umbrella trials for clinicians.
Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
[TBL] [Abstract][Full Text] [Related]
8. Unlocking the Potential: A Systematic Review of Master Protocol in Pediatrics.
Li Y; Nelson R; Izem R; Broglio K; Mundayat R; Gamalo M; Wen Y; Pan H; Sun H; Ye J
Ther Innov Regul Sci; 2024 Jul; 58(4):634-644. PubMed ID: 38653950
[TBL] [Abstract][Full Text] [Related]
9. Current usage and challenges of master protocols-based on survey results by ASA BIOP oncology methodology working group master protocol sub-team.
Li X; Lu C; Broglio K; Bycott P; Chen J; Jiang Q; Lin J; Ye J; Yin J
Ann Transl Med; 2022 Sep; 10(18):1036. PubMed ID: 36267733
[TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
11. Challenges with Novel Clinical Trial Designs: Master Protocols.
Cecchini M; Rubin EH; Blumenthal GM; Ayalew K; Burris HA; Russell-Einhorn M; Dillon H; Lyerly HK; Reaman GH; Boerner S; LoRusso PM
Clin Cancer Res; 2019 Apr; 25(7):2049-2057. PubMed ID: 30696689
[TBL] [Abstract][Full Text] [Related]
12. Master protocols and other innovative trial designs in inflammation and immunology to expedite clinical drug development.
Peeva E; Banerjee A; Banfield C; Soma K; Christensen J; Menon S; Vincent MS; Dolsten M
Drug Discov Today; 2024 May; 29(5):103948. PubMed ID: 38460567
[TBL] [Abstract][Full Text] [Related]
13. Novel Study Designs in Precision Medicine - Basket, Umbrella and Platform Trials.
Ravi R; Kesari HV
Curr Rev Clin Exp Pharmacol; 2022; 17(2):114-121. PubMed ID: 34455953
[TBL] [Abstract][Full Text] [Related]
14. The use of master protocols for efficient trial design to evaluate radiotherapy interventions: a systematic review.
Gilbert A; Samuel R; Cagney D; Sebag-Montefiore D; Brown J; Brown SR
J Natl Cancer Inst; 2024 Apr; ():. PubMed ID: 38720568
[TBL] [Abstract][Full Text] [Related]
15. Aiding the Adoption of Master Protocols by Optimizing Patient Engagement.
Huml RA; Collyar D; Antonijevic Z; Beckman RA; Quek RGW; Ye J
Ther Innov Regul Sci; 2023 Nov; 57(6):1136-1147. PubMed ID: 37615880
[TBL] [Abstract][Full Text] [Related]
16. Design and analysis of umbrella trials: Where do we stand?
Ouma LO; Wason JMS; Zheng H; Wilson N; Grayling M
Front Med (Lausanne); 2022; 9():1037439. PubMed ID: 36313987
[TBL] [Abstract][Full Text] [Related]
17. Master protocols: New directions in drug discovery.
Bogin V
Contemp Clin Trials Commun; 2020 Jun; 18():100568. PubMed ID: 32395664
[TBL] [Abstract][Full Text] [Related]
18. Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units.
Love SB; Cafferty F; Snowdon C; Carty K; Savage J; Pallmann P; McParland L; Brown L; Masters L; Schiavone F; Hague D; Townsend S; Amos C; South A; Sturgeon K; Langley R; Maughan T; James N; Hall E; Kernaghan S; Bliss J; Turner N; Tutt A; Yap C; Firth C; Kong A; Mehanna H; Watts C; Hills R; Thomas I; Copland M; Bell S; Sebag-Montefiore D; Jones R; Parmar MKB; Sydes MR
Trials; 2022 Sep; 23(1):757. PubMed ID: 36068599
[TBL] [Abstract][Full Text] [Related]
19. Definitions and statistical properties of master protocols for personalized medicine in oncology.
Renfro LA; Mandrekar SJ
J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
[TBL] [Abstract][Full Text] [Related]
20. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
